Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Entheon Biomedical Corp (ENTBF)

Entheon Biomedical Corp (ENTBF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K N/A
  • Shares Outstanding, K N/A
  • Annual Sales, $ 0 K
  • Annual Income, $ 0 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta N/A
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm N/A
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (N/A)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0617 +31.28%
on 04/09/25
0.0895 -9.50%
on 04/01/25
-0.0047 (-5.48%)
since 03/26/25
3-Month
0.0617 +31.28%
on 04/09/25
0.2730 -70.33%
on 02/10/25
-0.1651 (-67.09%)
since 01/28/25
52-Week
0.0225 +260.00%
on 06/18/24
0.2880 -71.88%
on 01/27/25
-0.0349 (-30.11%)
since 04/29/24

Most Recent Stories

More News
Entheon Announces Change of Directors

Vancouver, British Columbia--(Newsfile Corp. - April 4, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") announces the appointment of Harrison Newlands...

ENBI.CN : 0.1000 (-16.67%)
ENTBF : 0.0810 (-4.14%)
Entheon Issues Incentive Stock Options

Vancouver, British Columbia--(Newsfile Corp. - March 31, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") announces that the Company has granted options...

ENBI.CN : 0.1000 (-16.67%)
ENTBF : 0.0810 (-4.14%)
Entheon Announces Termination of Mentis AI Agreement

Vancouver, British Columbia--(Newsfile Corp. - March 14, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") announces that, further to its news release...

ENBI.CN : 0.1000 (-16.67%)
ENTBF : 0.0810 (-4.14%)
Entheon Announces Agreement to Acquire Mentis AI

Vancouver, British Columbia--(Newsfile Corp. - January 24, 2025) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU) ("Entheon" or the "Company") is pleased to announce that it has entered...

ENBI.CN : 0.1000 (-16.67%)
ENTBF : 0.0810 (-4.14%)
Cybin (NYSE American: CYBN) (NEO: CYBN) Poised to Accelerate CYB004 Clinical Program

Cybin (NYSE American: CYBN) (NEO: CYBN), a leading ethical biopharmaceutical company working to advance psychedelic therapeutics for various psychiatric and neurological conditions, has completed the acquisition...

ENBI.CN : 0.1000 (-16.67%)
CYBN.NE : 9.5000 (+1.39%)
CYBN : 6.79 (-0.29%)
ENTBF : 0.0810 (-4.14%)
Ketamine Ushering in New Era in the Pharmacology Therapies for Neurological Disorders

Palm Beach, FL – July 27, 2022 – For years, ketamine was known for its use as an anesthetic or as a recreational drug. Its ability to provide quick and safe sedation saved many lives during the Vietnam...

ENBI.CN : 0.1000 (-16.67%)
CMPS : 3.82 (+1.33%)
CYBN.NE : 9.5000 (+1.39%)
ATAI : 1.4950 (+6.03%)
FTRP : 0.8421 (+1.07%)
CYBN : 6.79 (-0.29%)
FTRP.TO : 1.09 (+5.83%)
ENTBF : 0.0810 (-4.14%)
SILO : 0.7266 (-10.30%)
Ketamine Ushering in New Era in the Pharmacology Therapies for Neurological Disorders

/PRNewswire/ -- For years, ketamine was known for its use as an anesthetic or as a recreational drug. Its ability to provide quick and safe sedation saved many...

CMPS : 3.82 (+1.33%)
ATAI : 1.4950 (+6.03%)
FTRP : 0.8421 (+1.07%)
CYBN : 6.79 (-0.29%)
ENTBF : 0.0810 (-4.14%)
FTRP.TO : 1.09 (+5.83%)
SILO : 0.7266 (-10.30%)
Cybin (NYSE American: CYBN) (NEO: CYBN) Acquires DMT Study

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that, through its wholly-owned subsidiary Cybin IRL Limited,...

ENBI.CN : 0.1000 (-16.67%)
CYBN.NE : 9.5000 (+1.39%)
CYBN : 6.79 (-0.29%)
ENTBF : 0.0810 (-4.14%)
Cybin Completes Acquisition of Phase 1 DMT Study from Entheon Biomedical

Cybin Inc. ( NEO:CYBN ) (NYSE American:CYBN) (“ Cybin ” or the “ Company ”), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics™”, today announced that, through...

ENBI.CN : 0.1000 (-16.67%)
CYBN.NE : 9.5000 (+1.39%)
CYBN : 6.79 (-0.29%)
ENTBF : 0.0810 (-4.14%)
Cybin Acquires DMT Clinical Study from Entheon Biomedical

Cybin Inc. ( NEO:CYBN ) (NYSE American:CYBN) ( Cybin or the Company ), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics™”, today announced that, through its wholly-owned...

ENBI.CN : 0.1000 (-16.67%)
CYBN.NE : 9.5000 (+1.39%)
CYBN : 6.79 (-0.29%)
ENTBF : 0.0810 (-4.14%)

Key Turning Points

3rd Resistance Point 0.0810
2nd Resistance Point 0.0810
1st Resistance Point 0.0810
Last Price 0.0810
1st Support Level 0.0810
2nd Support Level 0.0810
3rd Support Level 0.0810

See More

52-Week High 0.2880
Fibonacci 61.8% 0.1866
Fibonacci 50% 0.1552
Fibonacci 38.2% 0.1239
Last Price 0.0810
52-Week Low 0.0225

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar